CELL-DYN
®
3200 System Operator’s Manual
5-93
9140181H—October 2001
Section 5
Operating Instructions
Sample Analysis on the CELL-DYN 3200CS
Introduction
This section explains how samples are run on the CELL-DYN 3200CS models,
both Open and Closed Modes. Samples should not be run until daily QC checks
have been performed and the instrument is in the READY state. For convenience,
directions for Daily Start Up and QC are given in each section. Directions for
running samples in the Open Mode are also included in each section.
Samples may be analyzed whenever the
READY
message is displayed in the Status
Box on the
RUN
screen. Samples should be well mixed (a mechanical mixer is
preferred
3
) before they are run in the Open or Closed Mode on the instrument.
Instrument Preparation
1. Be sure that the green READY light on the Analyzer Status Indicator Panel
is illuminated.
2. If the Status Box on the
RUN
screen displays
STANDBY
or
INITIALIZED
,
press
[RUN]
to initiate the automatic Start Up cycle.
3. When the cycle is finished, a background count is automatically performed
and the Open Mode is selected.
4. Verify that the background counts are acceptable. If the background counts
are unacceptable, repeat the background cycle. If the counts are still
unacceptable, troubleshoot accordingly.
NOTE:
Backgrounds may be repeated by pressing the touch plate.
5. If controls will be processed in Closed Mode, press
[CHANGE SAMPLER]
.
6. Perform the daily Quality Control checks as directed in the following section.
Daily Quality Control Checks
Quality Control checks (which confirm calibration) should be performed on a daily
basis according to the laboratory’s protocol. Commercial control materials should
be properly warmed and mixed according to the manufacturer’s recommendations.
Patient controls should be handled according to the laboratory’s protocol.
WARNING: Potential Biohazard.
Consider all specimens and reagents,
controls, calibrators, etc., that contain human blood or serum as potentially
infectious. Wear gloves, lab coats, and safety glasses, and follow other
biosafety practices as specified in the OSHA Bloodborne Pathogen Rule
(29 CFR Part 1910.1030) or other equivalent biosafety procedures.
